PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA

NCT03006432 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

507

Enrollment

OTHER

Sponsor class

Conditions

OESOPHAGO-GASTRIC CARCINOMA

Interventions

DRUG: Oxaliplatin
DRUG: 5Fluorouracil bolus
DRUG: 5Fluorouracil continu
DRUG: Docetaxel
DRUG: Folinic Acid

Sponsor

Federation Francophone de Cancerologie Digestive

Collaborators

[object Object]
[object Object]